Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.4400
-0.0292 (-6.22%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Milestone Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9.42 | 8.97 | 8.63 | 9.83 | 8.81 | 10.3 | |
Revenue Growth | 3.72% | 3.99% | -12.19% | 11.60% | -14.54% | 89.52% |
Cost of Revenue | 2.8 | 2.57 | 2.2 | 3.03 | 3.91 | 3.99 |
Gross Profit | 6.62 | 6.41 | 6.43 | 6.79 | 4.9 | 6.31 |
Selling, General & Admin | 10.61 | 11.58 | 12.3 | 13.14 | 12.51 | 12.74 |
Research & Development | 0.04 | 0.45 | 0.86 | 0.7 | 1.15 | 0.88 |
Operating Expenses | 10.72 | 12.1 | 13.19 | 13.9 | 13.73 | 13.69 |
Operating Income | -4.1 | -5.7 | -6.76 | -7.11 | -8.83 | -7.38 |
Interest Expense | -0.04 | -0.03 | - | - | - | -0.02 |
Interest & Investment Income | - | - | 0.06 | 0.13 | 0.05 | - |
Earnings From Equity Investments | - | - | - | - | - | 0.24 |
Other Non Operating Income (Expenses) | - | - | 1.98 | - | - | - |
EBT Excluding Unusual Items | -4.14 | -5.72 | -4.71 | -6.98 | -8.77 | -7.15 |
Other Unusual Items | - | - | - | - | - | 0.28 |
Pretax Income | -4.14 | -5.72 | -4.71 | -6.98 | -8.77 | -6.88 |
Income Tax Expense | - | - | - | - | - | 0 |
Earnings From Continuing Operations | -4.14 | -5.72 | -4.71 | -6.98 | -8.77 | -6.88 |
Minority Interest in Earnings | - | - | - | 0.05 | 0.07 | 0.06 |
Net Income | -4.14 | -5.72 | -4.71 | -6.93 | -8.71 | -6.82 |
Net Income to Common | -4.14 | -5.72 | -4.71 | -6.93 | -8.71 | -6.82 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 85 | 82 | 80 | 73 | 71 | 69 |
Shares Outstanding (Diluted) | 85 | 82 | 80 | 73 | 71 | 69 |
Shares Change | 5.30% | 2.85% | 9.64% | 3.07% | 2.58% | 9.15% |
EPS (Basic) | -0.05 | -0.07 | -0.06 | -0.10 | -0.12 | -0.10 |
EPS (Diluted) | -0.05 | -0.07 | -0.06 | -0.10 | -0.12 | -0.10 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.66 | -2.93 | -2.93 | -5.33 | -6.04 | -4.05 |
Free Cash Flow Per Share | -0.01 | -0.04 | -0.04 | -0.07 | -0.09 | -0.06 |
Gross Margin | 70.23% | 71.40% | 74.56% | 69.12% | 55.65% | 61.25% |
Operating Margin | -43.56% | -63.48% | -78.30% | -72.31% | -100.25% | -71.60% |
Profit Margin | -43.98% | -63.77% | -54.62% | -70.51% | -98.87% | -66.17% |
Free Cash Flow Margin | -6.98% | -32.67% | -33.95% | -54.25% | -68.60% | -39.29% |
EBITDA | -4.03 | -5.62 | -6.72 | -7.04 | -8.76 | -7.3 |
EBITDA Margin | -42.73% | -62.61% | -77.86% | -71.68% | -99.52% | -70.89% |
D&A For EBITDA | 0.08 | 0.08 | 0.04 | 0.06 | 0.06 | 0.07 |
EBIT | -4.1 | -5.7 | -6.76 | -7.11 | -8.83 | -7.38 |
EBIT Margin | -43.56% | -63.48% | -78.30% | -72.31% | -100.25% | -71.60% |